市場調查報告書
商品編碼
1351550
尿液分析市場規模 - 按產品(消耗品、儀器)、按應用(泌尿道感染[UTI]、腎臟疾病、懷孕、糖尿病)、按最終用途(臨床實驗室、醫院、家庭保健)、全球預測2023 - 2032 年Urinalysis Market Size - By Product (Consumables, Instruments), By Application (Urinary Tract Infections [UTI], Kidney Disease, Pregnancy, Diabetes), By End-Use (Clinical Laboratories, Hospitals, Home Healthcare), Global Forecast 2023 - 2032 |
2023-2032 年全球尿液分析市場複合年成長率將達 5.2%。這是由於泌尿道感染和腎臟疾病的盛行率不斷增加。
據 CDC 稱,美國有近 3550 萬成年人患有慢性腎臟病。這推動了對尿液分析測試作為診斷工具的需求,從而推動市場成長。全球人口老化也導致慢性病發生率上升,因此需要定期進行尿液監測。不斷提高的醫療保健意識和積極的預防性醫療保健措施進一步推動了常規尿液檢測的採用。發展中地區醫療保健基礎設施的擴大以及對早期疾病檢測的日益重視可能會進一步推動市場擴張,使尿液分析成為現代醫療保健的重要組成部分。
整個尿液分析市場根據產品、應用、最終用途和地區進行分類。
根據產品,從2023 年到2032 年,儀器細分市場的複合年成長率將達到6.4%。隨著泌尿道感染和慢性腎臟疾病盛行率的不斷增加,人們對早期疾病檢測重要性的認知不斷增強,這將刺激對尿液分析儀器的需求,從而加速細分市場的成長。
糖尿病應用領域的尿液分析產業預計 2023 年至 2032 年複合年成長率為 9.3%。全球糖尿病流行不斷升級將推動該領域未來幾年的成長。不斷增加的糖尿病患者人數正在增加對尿糖和酮檢測的需求,並強調尿液分析在糖尿病管理和監測中的重要作用。
按最終用途分類,臨床實驗室領域預計在整個預測期內複合年成長率為 5.9%。對常規健康檢查的需求不斷增加、疾病盛行率不斷上升、診斷技術的進步以及預防性醫療保健的日益成長的趨勢將推動尿液分析程序在臨床實驗室中的採用。
從地區來看,從2023 年到2032 年,拉丁美洲(LATAM) 尿液分析行業將以4.3% 的複合年成長率成長。這一成長歸因於醫療保健支出的增加和醫療保健服務範圍的擴大。人口老化的加劇、預防保健意識的增強以及慢性病發病率的上升也推動了該地區對尿液分析檢測和服務的需求。
Global urinalysis market will reflect 5.2% CAGR over 2023-2032. This is attributed to the increasing prevalence of urinary tract infections and kidney diseases.
According to the CDC, nearly 35.5 million adults in the U.S. suffer from chronic kidney disease. This is propelling the demand for urinalysis tests as a diagnostic tool which will propel market growth. The aging global population is also contributing to a higher incidence of chronic diseases, necessitating regular urine monitoring. Rising healthcare awareness and proactive preventive healthcare measures are further boosting the adoption of routine urine testing. Expanding healthcare infrastructure in developing regions and the growing emphasis on early disease detection may further drive market expansion, making urinalysis a vital component of modern healthcare.
The overall urinalysis market is categorized based on product, application, end-use and region.
Based on product, the instrument segment will exhibit a 6.4% CAGR from 2023 to 2032. Growing awareness about the importance of early disease detection alongside the increasing prevalence of urinary tract infections and chronic kidney diseases will fuel demand for urinalysis instruments, accelerating segment growth.
Urinalysis industry from the diabetes application segment is expected to witness a 9.3% CAGR from 2023 to 2032. The escalating global diabetes epidemic will drive the segment growth in the forthcoming years. Increasing diabetic patient populations are boosting the demand for urine glucose and ketone testing, emphasizing the vital role of urinalysis in diabetes management and monitoring.
By end-use, clinical laboratories segment is expected to grow at a 5.9% CAGR throughout the forecast period. The increasing demand for routine health check-ups, rising disease prevalence, advancements in diagnostic technology, and the growing trend towards preventive healthcare will drive the adoption of urinalysis procedures in clinical laboratories.
Regionally, the Latin American (LATAM) urinalysis industry will grow at a 4.3% CAGR from 2023 to 2032. The growth is attributed to rising healthcare expenditure and expanding access to healthcare services. An increase in the aging population, growing awareness of preventive healthcare, and the rising incidence of chronic diseases are also boosting demand for urinalysis tests and services in the region.